Zeiss launch new solution updates

Article

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Amongst its offerings was the IOLMaster 500 which it claims is the fastest way of calculating the right IOL for every patient. It is part of the ZEISS Toric Solution and, via the FORUM platform, is an integral component of the ZEISS Ophthalmic Data Management Solution, a platform for the management of patient, diagnostic and OR data, for a paperless workflow in the doctor's practice and operating room.

The bitoric MICS intraocular lenses are a new standard range (lenses to +4.0 D cyl and 16-24 D sph) The lenses can be calculated quickly and simply using the Z CALC online calculator.

The AT LISA toric 909MV belongs to the ZEISS IOL family featuring violet filters. Besides UV protection these IOLS offer protection from the potentially more dangerous violet light spectrum. At the same time they transmit blue light, which plays an important role in regulation of the circadian rhythm, without impairing visual quality.

In the OVD Portfolio are the visco-elastic substances used for cataract treatment to enhance visibility of the operation area during the procedure and protect the corneal endothelium.

OPMI Lumera 700 is a surgical microscope which combines basic configuration with extensive options for surgery in the anterior and posterior ocular segments. The new RESIGHT 700 fundus viewing system and innovative Stereo Coaxial Illumination (SCI) illumination technology, allows the doctor to see the patient's eye with detail and brilliance.

Dr Ludwin Monz, President and CEO of Carl Zeiss Meditec AG said: “We have developed these innovations in close dialogue with our customers and we remain on course to further success as a solution provider for ophthalmology and therefore make a contribution to the more effective and efficient treatment of diseases.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.